Literature DB >> 26672558

Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.

Mayur Popat Pawar1, Shraddha Milind Pore2, Shekhar Nana Pradhan3, Shreyas Ramchandra Burute4, Umesh Yedu Bhoi5, Sunita Jaiprakash Ramanand2.   

Abstract

INTRODUCTION: Skin is the most commonly involved organ in adverse drug reactions. Most of the cutaneous adverse drug reactions (CADRs) being of mild to moderate severity are likely to be diagnosed and treated in an outpatient setting. Consequently, knowledge regarding morphological pattern, severity and drugs implicated in causation of these CADRs has important implications for healthcare personnel. AIM: To determine the current clinical pattern of CADRs and to assess their causality and severity with the help of standard scales. STUDY DESIGN AND
SETTING: A prospective, observational study was conducted in the outpatient department of skin and venereal disease in a tertiary care hospital.
MATERIALS AND METHODS: Patients with suspected CADR after consumption of systemic drug(s) were enrolled in the study. Data regarding demographics, clinical manifestations of CADR, drug history preceding the reaction, concomitant illness, relevant laboratory investigations etc was obtained. This data was then analysed for morphological pattern, causality and severity. CADRs with causality assessment possible and above on the basis of World Health Organization-Uppsala Monitoring Centre causality assessment system were considered for analysis. STATISTICS: Descriptive statistics were used to express results of pattern, severity and causality of CADRs.
RESULTS: Ninety patients were enrolled in the study. Male to female ratio for CADRs was 1:2.33. Maculopapular rash was most commonly encountered CADR in 76.67% cases followed by urticaria (8.89%), Stevens-Johnson syndrome (4.4%) and fixed dose eruptions (3.33%). Antiretrovirals were implicated in 75.56% (68/90) of CADRs. Nevirapine was suspected in 52 out of 90 (57.77%) cases of CADRs which included 39 cases of maculopapular rash, five cases of urticaria, four cases of Stevens-Johnson syndrome, and two cases each of pustular rash and angioedema respectively. Antimicrobials, antiepileptics and Non-steroidal Anti-inflammatory Drugs (NSAIDs) were other suspected drugs.
CONCLUSION: Antiretrovirals especially nevirapine was implicated in variety of CADRs ranging from maculopapular rash to life-threatening reactions like Stevens-Johnson syndrome in an outpatient setting. Women were twice as susceptible as men for CADRs.

Entities:  

Keywords:  Antiretroviral agents; Drug eruptions; Drug toxicity

Year:  2015        PMID: 26672558      PMCID: PMC4668429          DOI: 10.7860/JCDR/2015/13672.6768

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  27 in total

1.  Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009.

Authors:  Tai-Yin Wu; Min-Hua Jen; Alex Bottle; Mariam Molokhia; Paul Aylin; Derek Bell; Azeem Majeed
Journal:  J R Soc Med       Date:  2010-06       Impact factor: 5.344

2.  Adverse drug reactions reported in Indira Gandhi Government Medical College and Hospital, Nagpur.

Authors:  Meena Shrivastava; Ganesh Uchit; Ashish Chakravarti; Gajanan Joshi; Mohini Mahatme; Harshal Chaudhari
Journal:  J Assoc Physicians India       Date:  2011-05

3.  International drug monitoring: the role of national centres. Report of a WHO meeting.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1972

4.  Frequency of cutaneous reactions on rechallenge with nevirapine and delavirdine.

Authors:  M Gangar; G Arias; J G O'Brien; C A Kemper
Journal:  Ann Pharmacother       Date:  2000 Jul-Aug       Impact factor: 3.154

Review 5.  Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intracellular molecular signaling pathways.

Authors:  James B Macdonald; Brooke Macdonald; Loren E Golitz; Patricia LoRusso; Aleksandar Sekulic
Journal:  J Am Acad Dermatol       Date:  2015-02       Impact factor: 11.527

Review 6.  Sex differences in adverse reactions to antiretroviral drugs.

Authors:  Ighovwerha Ofotokun; Claire Pomeroy
Journal:  Top HIV Med       Date:  2003 Mar-Apr

Review 7.  Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.

Authors:  Chonlaphat Sukasem; Apichaya Puangpetch; Sadeep Medhasi; Wichittra Tassaneeyakul
Journal:  Asian Pac J Allergy Immunol       Date:  2014-06       Impact factor: 2.310

8.  Nevirapine-induced side effects in pregnant women: experience of a Brazilian university hospital.

Authors:  William Kondo; Elaine Aparecida Carraro; Elaine Prandel; Josiane Mourão Dias; Juliane Perini; Rodolfo Lara de Macedo; Taynah Cristina Cornelsen; Renato Sbalquiero; Maria das Graças Sasaki
Journal:  Braz J Infect Dis       Date:  2007-12       Impact factor: 1.949

9.  Changing incidence of nevirapine-induced cutaneous drug reactions: After revised guideline Nov 2011.

Authors:  Archana J Lokhande; Amita Sutaria; Bela J Shah; Asha N Shah
Journal:  Indian J Sex Transm Dis AIDS       Date:  2013-07

Review 10.  Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management.

Authors:  Evy Yunihastuti; Alvina Widhani; Teguh Harjono Karjadi
Journal:  Asia Pac Allergy       Date:  2014-01-31
View more
  2 in total

1.  Distribution of HLA-B Alleles and Haplotypes in Qatari: Recommendation for Establishing Pharmacogenomic Markers Screening for Drug Hypersensitivity.

Authors:  Mohammed Dashti; Abdullah Al-Matrouk; Arshad Channanath; Prashantha Hebbar; Fahd Al-Mulla; Thangavel Alphonse Thanaraj
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

2.  Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!

Authors:  Rajesh Kumar; Anupam Das; Sudip Das
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.